|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$21,926,350 |
|
|
Indirect Value
|
$61,758 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$21,988,108 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-10-01 |
4 |
AS |
$102.30 |
$1,300,225 |
D/D |
(12,417) |
115,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-17 |
4 |
D |
$292.85 |
$1,317,239 |
D/D |
(4,498) |
71,107 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-17 |
4 |
D |
$211.75 |
$1,321,320 |
D/D |
(6,240) |
55,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-10-01 |
4 |
AS |
$106.32 |
$1,337,377 |
D/D |
(12,417) |
42,264 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-09 |
4 |
D |
$422.74 |
$1,343,045 |
D/D |
(3,177) |
80,013 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-24 |
4 |
D |
$289.12 |
$1,362,912 |
D/D |
(4,714) |
61,590 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-05 |
4 |
AS |
$163.08 |
$1,386,180 |
D/D |
(8,500) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
67,846 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-27 |
4 |
AS |
$287.16 |
$1,447,143 |
D/D |
(5,034) |
56,556 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-13 |
4 |
AS |
$296.44 |
$1,460,816 |
D/D |
(4,887) |
82,003 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-24 |
4 |
AS |
$169.00 |
$1,515,761 |
D/D |
(8,969) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-21 |
4 |
AS |
$421.77 |
$1,519,637 |
D/D |
(3,603) |
59,439 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-12-13 |
4 |
OE |
$187.53 |
$1,613,321 |
D/D |
8,603 |
65,159 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-24 |
4 |
D |
$227.86 |
$1,651,074 |
D/D |
(7,246) |
65,066 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-18 |
4 |
AS |
$210.05 |
$1,657,481 |
D/D |
(7,825) |
47,635 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-06-01 |
4 |
AS |
$124.00 |
$1,685,656 |
D/D |
(13,594) |
131,467 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-08-09 |
4 |
AS |
$300.53 |
$1,710,817 |
D/D |
(5,690) |
60,996 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
86,890 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-12 |
4 |
AS |
$420.24 |
$1,804,931 |
D/D |
(4,295) |
75,718 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
71,219 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-14 |
4 |
AS |
$295.84 |
$1,910,962 |
D/D |
(6,398) |
75,605 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-07-21 |
4 |
AS |
$159.00 |
$2,011,271 |
D/D |
(12,475) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-20 |
4 |
AS |
$420.79 |
$2,021,475 |
D/D |
(4,804) |
63,042 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-23 |
4 |
D |
$431.79 |
$2,035,458 |
D/D |
(4,714) |
54,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-26 |
4 |
AS |
$425.70 |
$2,142,974 |
D/D |
(5,034) |
49,691 |
0 |
% |
|
192 Records found
|
|
Page 7 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|